The Clinical Utility and Safety of Biomarker-Guided Immunosuppression Withdrawal in Liver Transplantation: the LIFT Prospective RCT

Julien Vionnet,Rosa Miquel, Juan G Abraldes,Juan-Jose Lozano,Pablo Ruiz, Miquel Navasa,Aileen Marshall,Frederik Nevens,William Gelson, Joanna Leithead,Steven Masson,Elmar Jaeckel,Richard Taubert,Phaedra Tachtatzis,Dennis Eurich,Kenneth Simpson,Eliano Bonaccorsi-Riani,James Ferguson,Alberto Quaglia, Maria Elstad, Marc Delord, Abdel Douiri, Alberto Sánchez-Fueyo

Efficacy and Mechanism Evaluation（2025）

Cited 0|Views0

Key words

humans,adult,middle aged,liver transplantation,prospective studies,arm,berlin,cause of death,control groups,elasticity imaging techniques,incidence,london,prevalence,weaning,neoplasms,immunosuppression therapy,liver,biomarkers,outcome assessment,health care,transaminases,allografts,biopsy,randomised controlled trials as topic,multicentre studies as topic,clinical trials,phase iv as topic,liver transplantation

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined